- Home
- LUMO vs LTRN Comparison
LUMO vs LTRN Comparison
Compare LUMO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUMO
- LTRN
- Stock Information
- Founded
- LUMO 2011
- LTRN 2013
- Country
- LUMO United States
- LTRN United States
- Employees
- LUMO N/A
- LTRN N/A
- Industry
- LUMO Biotechnology: Pharmaceutical Preparations
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- LUMO Health Care
- LTRN Health Care
- Exchange
- LUMO Nasdaq
- LTRN Nasdaq
- Market Cap
- LUMO 37.4M
- LTRN 36.2M
- IPO Year
- LUMO N/A
- LTRN 2020
- Fundamental
- Price
- LUMO $4.34
- LTRN $3.42
- Analyst Decision
- LUMO Buy
- LTRN Hold
- Analyst Count
- LUMO 4
- LTRN 1
- Target Price
- LUMO $9.38
- LTRN N/A
- AVG Volume (30 Days)
- LUMO 133.0K
- LTRN 79.1K
- Earning Date
- LUMO 11-07-2024
- LTRN 11-07-2024
- Dividend Yield
- LUMO N/A
- LTRN N/A
- EPS Growth
- LUMO N/A
- LTRN N/A
- EPS
- LUMO N/A
- LTRN N/A
- Revenue
- LUMO $2,205,000.00
- LTRN N/A
- Revenue This Year
- LUMO $184.11
- LTRN N/A
- Revenue Next Year
- LUMO N/A
- LTRN N/A
- P/E Ratio
- LUMO N/A
- LTRN N/A
- Revenue Growth
- LUMO 26.94
- LTRN N/A
- 52 Week Low
- LUMO $1.37
- LTRN $2.79
- 52 Week High
- LUMO $4.58
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- LUMO 4.26
- LTRN 47.65
- Support Level
- LUMO $4.31
- LTRN $3.28
- Resistance Level
- LUMO $4.39
- LTRN $4.88
- Average True Range (ATR)
- LUMO 0.03
- LTRN 0.40
- MACD
- LUMO -0.44
- LTRN -0.01
- Stochastic Oscillator
- LUMO 0.00
- LTRN 15.91
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.